Pitfalls When Determining HNA-1 Genotypes and Finding Novel Alleles
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25169127 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Kirstine Kløve-Mogensen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology, Aalborg University Hospital, 9000 Aalborg, Denmark. Hauptthemen laut MEDLINE: Alleles, Genotype, GPI-Linked Proteins, Receptors, IgG. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beckett-Fonden, Aalborg Frivillige Bloddonorers Fond, Region Nordjyllands Sundhedsvidenskabelige Forskningsfond.
Abstract (Originalsprache)
Genetic variation in the FCGR3B gene is responsible for different variants of human neutrophil antigen 1 (HNA-1). Laboratory techniques currently utilized for routine HNA-1 genotyping, predominantly PCR-sequence-specific primer (PCR-SSP) and PCR-sequence-based typing (PCR-SBT), lack specificity for FCGR3B. This study compares the capabilities and limitations of existing technologies including an in-house TaqMan PCR, a commercial PCR-SSP test, PCR-SBT and multiplex ligation-dependent probe amplification (MLPA) with those of a long-read nanopore sequencing assay. Testing was performed with both related and unrelated Danish samples with different copy numbers and/or rare alleles. Long-read nanopore sequencing was validated by blind testing of ten English samples. The results showed that FCGR3B copy numbers correlate with a dose-dependent distribution of alleles that complicates genotyping by TaqMan PCR, PCR-SSP and PCR-SBT, due to co-amplification of the homologous FCGR3A gene. MLPA can correctly quantify the dose-dependent distribution but not detect novel variants. Long-read nanopore sequencing showed high specificity for FCGR3B and was able to detect dosage-dependent distribution, and rare and novel variants that were previously not described. Current HNA-1 genotyping methods cannot produce unambiguous allele-level results, whereas long-read nanopore sequencing has shown the potential to resolve observed ambiguities, identify new HNA-1 variants and allow definitive allele assignment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Immunology, Aalborg University Hospital, 9000 Aalborg, Denmark.
- Service Development Laboratory, NHS Blood and Transplant, London NW9 5BG, UK.
- Department of Clinical Medicine, Aalborg University, 9000 Aalborg, Denmark.
- Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark.
ORCID-Profile: Kirstine Kløve-Mogensen, Tom Browne
Förderung
- Beckett-Fonden
- Aalborg Frivillige Bloddonorers Fond
- Region Nordjyllands Sundhedsvidenskabelige Forskningsfond
- Beckett Foundation
- Aalborg Voluntary Blood Donors Foundation
- North Denmark Region Health Science Research Foundation
Zitieren
APA
Kløve-Mogensen, K., Browne, T., Haunstrup, T. M., & Steffensen, R. (2024). Pitfalls When Determining HNA-1 Genotypes and Finding Novel Alleles. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25169127
Vancouver
Kløve-Mogensen K, Browne T, Haunstrup TM, Steffensen R. Pitfalls When Determining HNA-1 Genotypes and Finding Novel Alleles. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25169127
BibTeX
@article{KlveMogensen2024,
author = {Kløve-Mogensen, Kirstine and Browne, Tom and Haunstrup, Thure Mors and Steffensen, Rudi},
title = {Pitfalls When Determining HNA-1 Genotypes and Finding Novel Alleles},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25169127}
}
EUVIMED